Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1188-1200.e19
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Prabhu S. Arunachalam, Alexandra C. Walls, Nadia Golden, et al.
Nature (2021) Vol. 594, Iss. 7862, pp. 253-258
Open Access | Times Cited: 307
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
Michael Joyce, Wei‐Hung Chen, Rajeshwer S. Sankhala, et al.
Cell Reports (2021) Vol. 37, Iss. 12, pp. 110143-110143
Open Access | Times Cited: 149
Antibodies to combat viral infections: development strategies and progress
Giuseppe Pantaleo, Bruno E. Correia, Craig Fenwick, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 676-696
Open Access | Times Cited: 138
Microneedle-Mediated Vaccination: Innovation and Translation
Tao Sheng, Bowen Luo, Wentao Zhang, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113919-113919
Closed Access | Times Cited: 110
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 109
Protein Cages: From Fundamentals to Advanced Applications
Thomas G. W. Edwardson, Mikail D. Levasseur, Stephan Tetter, et al.
Chemical Reviews (2022) Vol. 122, Iss. 9, pp. 9145-9197
Closed Access | Times Cited: 96
Machine learning for functional protein design
Pascal Notin, Nathan Rollins, Yarin Gal, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 2, pp. 216-228
Closed Access | Times Cited: 72
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Zezhong Liu, Jie Zhou, Wei Xu, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 269-287
Open Access | Times Cited: 71
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study
Elke Wynberg, Alvin X. Han, Anders Boyd, et al.
Vaccine (2022) Vol. 40, Iss. 32, pp. 4424-4431
Open Access | Times Cited: 71
A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering
Nishta Krishnan, Yao Jiang, Jiarong Zhou, et al.
Nature Nanotechnology (2023) Vol. 19, Iss. 3, pp. 345-353
Closed Access | Times Cited: 51
Rapid and automated design of two-component protein nanomaterials using ProteinMPNN
Robbert J. de Haas, Natalie Brunette, Alex Goodson, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 13
Open Access | Times Cited: 16
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
Tom G. Caniels, Ilja Bontjer, Karlijn van der Straten, et al.
Science Advances (2021) Vol. 7, Iss. 36
Open Access | Times Cited: 99
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
David A. Meekins, Natasha N. Gaudreault, Jüergen A. Richt
Viruses (2021) Vol. 13, Iss. 10, pp. 1993-1993
Open Access | Times Cited: 93
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata S. Bollimpelli, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 88
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
Nanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara, et al.
Immunity (2021) Vol. 54, Iss. 3, pp. 542-556.e9
Open Access | Times Cited: 84
Current and future nanoparticle vaccines for COVID-19
Mai N. Vu, Hannah G. Kelly, Stephen J. Kent, et al.
EBioMedicine (2021) Vol. 74, pp. 103699-103699
Open Access | Times Cited: 80
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Marloes Grobben, Karlijn van der Straten, Philip J. M. Brouwer, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 63
Failures of quarantine systems for preventing COVID‐19 outbreaks in Australia and New Zealand
Leah Grout, Ameera Katar, Driss Ait Ouakrim, et al.
The Medical Journal of Australia (2021) Vol. 215, Iss. 7, pp. 320-324
Open Access | Times Cited: 62
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
Leanne P. M. van Leeuwen, Corine H. GeurtsvanKessel, Pauline M. Ellerbroek, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1949-1957
Open Access | Times Cited: 60
Prevention of host-to-host transmission by SARS-CoV-2 vaccines
Darius Mostaghimi, Caroline N Valdez, Haleigh Tianna Larson, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. e52-e58
Open Access | Times Cited: 57
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
Mathieu Claireaux, Tom G. Caniels, Marlon de Gast, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens
Benjamin J. Read, Lori Won, John C. Kraft, et al.
Cell Reports (2022) Vol. 38, Iss. 2, pp. 110217-110217
Open Access | Times Cited: 43
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants
Yinfeng Kang, Cong Sun, Jing Sun, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Engineering nanomaterial physical characteristics for cancer immunotherapy
DaeYong Lee, Kristin Huntoon, Jacques Lux, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 7, pp. 499-517
Closed Access | Times Cited: 36
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top